Afuco™ Anti-Human PTPRC ADCC Therapeutic Antibody, ADCC Enhanced

Anti-PTPRC ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies specifically recognize the human CD45 isoform RB, and may be used to block undesirable immune reactions in patients with transplant rejection and autoimmune diseases such as rheumatoid arthritis, multiple sclerosis and autoimmune diabetes.
Supplier Creative Biolabs
Product # AFC-695CL
Pricing Inquiry
Host Human
Target PTPRC
Species Reactivity Human
Type ADCC enhanced antibody
Storage 4 °C, -20°C if preferred
Feedback